Evidence map›Paper›PMID 26491700›Full record

ArticleJournal of immunology research2015

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria.

James M Colborn, Joni H Ylöstalo, Ousmane A Koita, Ousmane H Cissé, Donald J Krogstad

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Effect of neem leaf extract (Veterinary world · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Accelerator or Brake: Immune Regulators in Malaria.Frontiers in cellular and infection microbiology · 2020
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

James M ColbornCenter for Infectious Diseases, Tulane University Health Sciences Center, New Orleans, LA 70112, USA ; Department of Tropical Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA ; Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA.
Joni H YlöstaloCenter for Gene Therapy, Tulane University Health Sciences Center, New Orleans, LA 70112, USA ; Department of Biology, University of Mary Hardin-Baylor, 900 College Street, Box 8432, Belton, TX 76513, USA.
Ousmane A KoitaThe Faculties of Science, Technology, Medicine, Pharmacy, and Odontostomatology, University of Bamako, Bamako, Mali.
Ousmane H CisséThe Faculties of Science, Technology, Medicine, Pharmacy, and Odontostomatology, University of Bamako, Bamako, Mali ; Institute of Microbiology, University of Lausanne, 1011 Lausanne, Switzerland.
Donald J KrogstadCenter for Infectious Diseases, Tulane University Health Sciences Center, New Orleans, LA 70112, USA ; Department of Tropical Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA ; Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.
Centers for Disease Control and Prevention · USTulane University · USUniversity of Bamako · MLUniversity of Lausanne · CHUniversity of Mary Hardin–Baylor · US

Funding

Sequencing and Genomics CoresU19AI089696 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI DOUMBIA, SEYDOU · 2010 to 2016
$10.6M
Development and Testing of New Antimalarial DrugsU01CI000211 · CI · UNIVERSITY OF MISSISSIPPI · PI AVERY, MITCHELL ALLEN · 2004 to 2009
$7.0M
Phase 2 Studies of AQ-13, an Investigative AntimalarialR01FD003373 · FDA · TULANE UNIVERSITY OF LOUISIANA · PI KROGSTAD, DONALD JOHN · 2009 to 2015
$1.2M
FDA HHS R01 FD003373NCPDCID CDC HHS U01 CI 000211NCPDCID CDC HHS U01 CI000211NIAID NIH HHS U19 AI089696PHS HHS CCU/UR3 418652
6 · The paper itself

Abstract

To examine human gene expression during uncomplicated P. falciparum malaria, we obtained three samples (acute illness, treatment, and recovery) from 10 subjects and utilized each subject's recovery sample as their baseline. At the time of acute illness (day 1), subjects had upregulation of innate immune response, cytokine, and inflammation-related genes (IL-1β, IL-6, TNF, and IFN-γ), which was more frequent with parasitemias >100,000 per μL and body temperatures ≥ 39°C. Apoptosis-related genes (Fas, BAX, and TP53) were upregulated acutely and for several days thereafter (days 1-3). In contrast, the expression of immune-modulatory (transcription factor 7, HLV-DOA, and CD6) and apoptosis inhibitory (c-myc, caspase 8, and Fas Ligand G) genes was downregulated initially and returned to normal with clinical recovery (days 7-10). These results indicate that the innate immune response, cytokine, and apoptosis pathways are upregulated acutely in uncomplicated malaria with concomitant downregulation of immune-modulatory and apoptosis inhibitory genes.

Indexed as

Gene ExpressionAdolescentApoptosisCase-Control StudiesChildChild, PreschoolCluster AnalysisComputational BiologyFemaleGene Expression ProfilingGene Regulatory NetworksHumansLeukocytes, MononuclearMalaria, FalciparumMaleParasitemia

Identifiers

PMID26491700
PMCPMC4605373
OpenAlexW2144662025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.